APO Research
Talk to an analyst

APO RESEARCH · REPORT

Multiplex Molecular Diagnosis Technology

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Multiplex Molecular Diagnosis Technology Market Analysis and Forecast 2026-2032

17 January 2026197 pages

Choose your research edition.

Industry ResearchMultiplex Molecular Diagnosis Technology Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Multiplex Molecular Diagnosis Technology Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Multiplex Molecular Diagnosis Technology Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Multiplex Molecular Diagnosis Technology Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Multiplex Molecular Diagnosis Technology Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Multiplex Molecular Diagnosis Technology market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Multiplex Molecular Diagnosis Technology is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Multiplex Molecular Diagnosis Technology is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Multiplex Molecular Diagnosis Technology is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Multiplex Molecular Diagnosis Technology is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Multiplex Molecular Diagnosis Technology include Siemens, Hologic, Thermo Fisher Scientific, Koninklijke Philips N.V., NeuroLogica, Shimadzu Medical, GENERAL ELECTRIC, Sysmex and Canon, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Multiplex Molecular Diagnosis Technology, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Multiplex Molecular Diagnosis Technology, also provides the revenue of main regions and countries. Of the upcoming market potential for Multiplex Molecular Diagnosis Technology, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Multiplex Molecular Diagnosis Technology revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Multiplex Molecular Diagnosis Technology market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Multiplex Molecular Diagnosis Technology revenue, projected growth trends, production technology, application and end-user industry.

Multiplex Molecular Diagnosis Technology Segment by Company

Siemens

Hologic

Thermo Fisher Scientific

Koninklijke Philips N.V.

NeuroLogica

Shimadzu Medical

GENERAL ELECTRIC

Sysmex

Canon

FUJIFILM Holdings

Bio-Rad Laboratories

Roche Diagnostics

Luminex Corporation

Abbott Laboratories

QIAGEN

Multiplex Molecular Diagnosis Technology Segment by Type

Real-time PCR

Nested PCR with Melt Curve Analysis

PCR with Low Density Microarray

PCR with Liquid Phase Bead Array

PCR with Electrochemical Detection

Multiplex Molecular Diagnosis Technology Segment by Application

Hospital

Outpatient Surgery Centre

Others

Multiplex Molecular Diagnosis Technology Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Multiplex Molecular Diagnosis Technology market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Multiplex Molecular Diagnosis Technology and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Multiplex Molecular Diagnosis Technology.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Multiplex Molecular Diagnosis Technology in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Multiplex Molecular Diagnosis Technology company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Multiplex Molecular Diagnosis Technology revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Multiplex Molecular Diagnosis Technology Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Real-time PCR Major Player Table 3. Nested PCR with Melt Curve Analysis Major Player Table 4. PCR with Low Density Microarray Major Player Table 5. PCR with Liquid Phase Bead Array Major Player Table 6. PCR with Electrochemical Detection Major Player Table 7. Global Multiplex Molecular Diagnosis Technology Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Hospital Major Player Table 9. Outpatient Surgery Centre Major Player Table 10. Others Major Player Table 11. Multiplex Molecular Diagnosis Technology Industry Trends Table 12. Multiplex Molecular Diagnosis Technology Industry Drivers Table 13. Multiplex Molecular Diagnosis Technology Industry Opportunities and Challenges Table 14. Multiplex Molecular Diagnosis Technology Industry Restraints Table 15. Global Multiplex Molecular Diagnosis Technology Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 16. Global Multiplex Molecular Diagnosis Technology Market Size by Region (2021-2026) & (US$ Million) Table 17. Global Multiplex Molecular Diagnosis Technology Market Share by Region (2021-2026) Table 18. Global Multiplex Molecular Diagnosis Technology Market Size by Region (2027-2032) & (US$ Million) Table 19. Global Multiplex Molecular Diagnosis Technology Market Share by Region (2027-2032) Table 20. Global Multiplex Molecular Diagnosis Technology Revenue by Players (US$ Million) & (2021-2026) Table 21. Global Multiplex Molecular Diagnosis Technology Revenue Market Share by Players (2021-2026) Table 22. Global Multiplex Molecular Diagnosis Technology Key Players Ranking, 2024 VS 2025 VS 2026 Table 23. Global Multiplex Molecular Diagnosis Technology Key Players Headquarters & Area Served Table 24. Global Multiplex Molecular Diagnosis Technology Players, Product Type & Application Table 25. Global Multiplex Molecular Diagnosis Technology Players Establishment Date Table 26. Global Players Market Concentration Ratio (CR5 and HHI) Table 27. Global Multiplex Molecular Diagnosis Technology by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 28. Global Multiplex Molecular Diagnosis Technology Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Multiplex Molecular Diagnosis Technology Revenue by Type (2021-2026) & (US$ Million) Table 30. Global Multiplex Molecular Diagnosis Technology Revenue by Type (2027-2032) & (US$ Million) Table 31. Global Multiplex Molecular Diagnosis Technology Revenue Market Share by Type (2021-2026) Table 32. Global Multiplex Molecular Diagnosis Technology Revenue Market Share by Type (2027-2032) Table 33. Global Multiplex Molecular Diagnosis Technology Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Multiplex Molecular Diagnosis Technology Revenue by Application (2021-2026) & (US$ Million) Table 35. Global Multiplex Molecular Diagnosis Technology Revenue by Application (2027-2032) & (US$ Million) Table 36. Global Multiplex Molecular Diagnosis Technology Revenue Market Share by Application (2021-2026) Table 37. Global Multiplex Molecular Diagnosis Technology Revenue Market Share by Application (2027-2032) Table 38. Siemens Company Information Table 39. Siemens Business Overview Table 40. Siemens Multiplex Molecular Diagnosis Technology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. Siemens Multiplex Molecular Diagnosis Technology Product Portfolio Table 42. Siemens Recent Development Table 43. Hologic Company Information Table 44. Hologic Business Overview Table 45. Hologic Multiplex Molecular Diagnosis Technology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. Hologic Multiplex Molecular Diagnosis Technology Product Portfolio Table 47. Hologic Recent Development Table 48. Thermo Fisher Scientific Company Information Table 49. Thermo Fisher Scientific Business Overview Table 50. Thermo Fisher Scientific Multiplex Molecular Diagnosis Technology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. Thermo Fisher Scientific Multiplex Molecular Diagnosis Technology Product Portfolio Table 52. Thermo Fisher Scientific Recent Development Table 53. Koninklijke Philips N.V. Company Information Table 54. Koninklijke Philips N.V. Business Overview Table 55. Koninklijke Philips N.V. Multiplex Molecular Diagnosis Technology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. Koninklijke Philips N.V. Multiplex Molecular Diagnosis Technology Product Portfolio Table 57. Koninklijke Philips N.V. Recent Development Table 58. NeuroLogica Company Information Table 59. NeuroLogica Business Overview Table 60. NeuroLogica Multiplex Molecular Diagnosis Technology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. NeuroLogica Multiplex Molecular Diagnosis Technology Product Portfolio Table 62. NeuroLogica Recent Development Table 63. Shimadzu Medical Company Information Table 64. Shimadzu Medical Business Overview Table 65. Shimadzu Medical Multiplex Molecular Diagnosis Technology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. Shimadzu Medical Multiplex Molecular Diagnosis Technology Product Portfolio Table 67. Shimadzu Medical Recent Development Table 68. GENERAL ELECTRIC Company Information Table 69. GENERAL ELECTRIC Business Overview Table 70. GENERAL ELECTRIC Multiplex Molecular Diagnosis Technology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. GENERAL ELECTRIC Multiplex Molecular Diagnosis Technology Product Portfolio Table 72. GENERAL ELECTRIC Recent Development Table 73. Sysmex Company Information Table 74. Sysmex Business Overview Table 75. Sysmex Multiplex Molecular Diagnosis Technology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 76. Sysmex Multiplex Molecular Diagnosis Technology Product Portfolio Table 77. Sysmex Recent Development Table 78. Canon Company Information Table 79. Canon Business Overview Table 80. Canon Multiplex Molecular Diagnosis Technology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 81. Canon Multiplex Molecular Diagnosis Technology Product Portfolio Table 82. Canon Recent Development Table 83. FUJIFILM Holdings Company Information Table 84. FUJIFILM Holdings Business Overview Table 85. FUJIFILM Holdings Multiplex Molecular Diagnosis Technology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 86. FUJIFILM Holdings Multiplex Molecular Diagnosis Technology Product Portfolio Table 87. FUJIFILM Holdings Recent Development Table 88. Bio-Rad Laboratories Company Information Table 89. Bio-Rad Laboratories Business Overview Table 90. Bio-Rad Laboratories Multiplex Molecular Diagnosis Technology Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. Bio-Rad Laboratories Multiplex Molecular Diagnosis Technology Product Portfolio Table 92. Bio-Rad Laboratories Recent Development Table 93. Roche Diagnostics Company Information Table 94. Roche Diagnostics Business Overview Table 95. Roche Diagnostics Multiplex Molecular Diagnosis Technology Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Roche Diagnostics Multiplex Molecular Diagnosis Technology Product Portfolio Table 97. Roche Diagnostics Recent Development Table 98. Luminex Corporation Company Information Table 99. Luminex Corporation Business Overview Table 100. Luminex Corporation Multiplex Molecular Diagnosis Technology Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Luminex Corporation Multiplex Molecular Diagnosis Technology Product Portfolio Table 102. Luminex Corporation Recent Development Table 103. Abbott Laboratories Company Information Table 104. Abbott Laboratories Business Overview Table 105. Abbott Laboratories Multiplex Molecular Diagnosis Technology Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. Abbott Laboratories Multiplex Molecular Diagnosis Technology Product Portfolio Table 107. Abbott Laboratories Recent Development Table 108. QIAGEN Company Information Table 109. QIAGEN Business Overview Table 110. QIAGEN Multiplex Molecular Diagnosis Technology Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. QIAGEN Multiplex Molecular Diagnosis Technology Product Portfolio Table 112. QIAGEN Recent Development Table 113. North America Multiplex Molecular Diagnosis Technology Revenue by Type (2021-2026) & (US$ Million) Table 114. North America Multiplex Molecular Diagnosis Technology Revenue by Type (2027-2032) & (US$ Million) Table 115. North America Multiplex Molecular Diagnosis Technology Revenue by Application (2021-2026) & (US$ Million) Table 116. North America Multiplex Molecular Diagnosis Technology Revenue by Application (2027-2032) & (US$ Million) Table 117. North America Multiplex Molecular Diagnosis Technology Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 118. North America Multiplex Molecular Diagnosis Technology Revenue by Country (2021-2026) & (US$ Million) Table 119. North America Multiplex Molecular Diagnosis Technology Revenue by Country (US$ Million) & (2027-2032) Table 120. Europe Multiplex Molecular Diagnosis Technology Revenue by Type (2021-2026) & (US$ Million) Table 121. Europe Multiplex Molecular Diagnosis Technology Revenue by Type (2027-2032) & (US$ Million) Table 122. Europe Multiplex Molecular Diagnosis Technology Revenue by Application (2021-2026) & (US$ Million) Table 123. Europe Multiplex Molecular Diagnosis Technology Revenue by Application (2027-2032) & (US$ Million) Table 124. Europe Multiplex Molecular Diagnosis Technology Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 125. Europe Multiplex Molecular Diagnosis Technology Revenue by Country (2021-2026) & (US$ Million) Table 126. Europe Multiplex Molecular Diagnosis Technology Revenue by Country (US$ Million) & (2027-2032) Table 127. China Multiplex Molecular Diagnosis Technology Revenue by Type (2021-2026) & (US$ Million) Table 128. China Multiplex Molecular Diagnosis Technology Revenue by Type (2027-2032) & (US$ Million) Table 129. China Multiplex Molecular Diagnosis Technology Revenue by Application (2021-2026) & (US$ Million) Table 130. China Multiplex Molecular Diagnosis Technology Revenue by Application (2027-2032) & (US$ Million) Table 131. Asia Multiplex Molecular Diagnosis Technology Revenue by Type (2021-2026) & (US$ Million) Table 132. Asia Multiplex Molecular Diagnosis Technology Revenue by Type (2027-2032) & (US$ Million) Table 133. Asia Multiplex Molecular Diagnosis Technology Revenue by Application (2021-2026) & (US$ Million) Table 134. Asia Multiplex Molecular Diagnosis Technology Revenue by Application (2027-2032) & (US$ Million) Table 135. Asia Multiplex Molecular Diagnosis Technology Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 136. Asia Multiplex Molecular Diagnosis Technology Revenue by Region (US$ Million) & (2021-2026) Table 137. Asia Multiplex Molecular Diagnosis Technology Revenue by Region (US$ Million) & (2027-2032) Table 138. SAMEA Multiplex Molecular Diagnosis Technology Revenue by Type (2021-2026) & (US$ Million) Table 139. SAMEA Multiplex Molecular Diagnosis Technology Revenue by Type (2027-2032) & (US$ Million) Table 140. SAMEA Multiplex Molecular Diagnosis Technology Revenue by Application (2021-2026) & (US$ Million) Table 141. SAMEA Multiplex Molecular Diagnosis Technology Revenue by Application (2027-2032) & (US$ Million) Table 142. SAMEA Multiplex Molecular Diagnosis Technology Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 143. SAMEA Multiplex Molecular Diagnosis Technology Revenue by Country (2021-2026) & (US$ Million) Table 144. SAMEA Multiplex Molecular Diagnosis Technology Revenue by Country (US$ Million) & (2027-2032) Table 145. Research Programs/Design for This Report Table 146. Authors List of This Report Table 147. Secondary Sources Table 148. Primary Sources List of Figures Figure 1. Multiplex Molecular Diagnosis Technology Image Figure 2. Global Multiplex Molecular Diagnosis Technology Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Multiplex Molecular Diagnosis Technology Market Size Share 2021 VS 2025 VS 2032 Figure 4. Real-time PCR Image Figure 5. Nested PCR with Melt Curve Analysis Image Figure 6. PCR with Low Density Microarray Image Figure 7. PCR with Liquid Phase Bead Array Image Figure 8. PCR with Electrochemical Detection Image Figure 9. Global Multiplex Molecular Diagnosis Technology Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Multiplex Molecular Diagnosis Technology Market Size Share 2021 VS 2025 VS 2032 Figure 11. Hospital Image Figure 12. Outpatient Surgery Centre Image Figure 13. Others Image Figure 14. Global Multiplex Molecular Diagnosis Technology Market Size (US$ Million) & (2021-2032) Figure 15. Global Multiplex Molecular Diagnosis Technology Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Multiplex Molecular Diagnosis Technology Market Share by Region: 2021 VS 2025 VS 2032 Figure 17. Global Multiplex Molecular Diagnosis Technology Players Revenue Share Top 10 and Top 5 in 2025 Figure 18. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Multiplex Molecular Diagnosis Technology Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Multiplex Molecular Diagnosis Technology Revenue Market Share 2021 VS 2025 VS 2032 Figure 21. Global Multiplex Molecular Diagnosis Technology Revenue Market Share by Type (2021-2032) Figure 22. Global Multiplex Molecular Diagnosis Technology Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Multiplex Molecular Diagnosis Technology Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 24. Global Multiplex Molecular Diagnosis Technology Revenue Market Share by Application (2021-2032) Figure 25. North America Multiplex Molecular Diagnosis Technology Revenue YoY Growth (2021-2032) & (US$ Million) Figure 26. North America Multiplex Molecular Diagnosis Technology Revenue Share by Type (2021-2032) Figure 27. North America Multiplex Molecular Diagnosis Technology Revenue Share by Application (2021-2032) Figure 28. North America Multiplex Molecular Diagnosis Technology Revenue Share by Country (2021-2032) Figure 29. United States Multiplex Molecular Diagnosis Technology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Canada Multiplex Molecular Diagnosis Technology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Mexico Multiplex Molecular Diagnosis Technology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Europe Multiplex Molecular Diagnosis Technology Revenue YoY Growth (2021-2032) & (US$ Million) Figure 33. Europe Multiplex Molecular Diagnosis Technology Revenue Share by Type (2021-2032) Figure 34. Europe Multiplex Molecular Diagnosis Technology Revenue Share by Application (2021-2032) Figure 35. Europe Multiplex Molecular Diagnosis Technology Revenue Share by Country (2021-2032) Figure 36. Germany Multiplex Molecular Diagnosis Technology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. France Multiplex Molecular Diagnosis Technology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. U.K. Multiplex Molecular Diagnosis Technology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Italy Multiplex Molecular Diagnosis Technology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Spain Multiplex Molecular Diagnosis Technology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Russia Multiplex Molecular Diagnosis Technology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Netherlands Multiplex Molecular Diagnosis Technology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Nordic Countries Multiplex Molecular Diagnosis Technology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. China Multiplex Molecular Diagnosis Technology Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. China Multiplex Molecular Diagnosis Technology Revenue Share by Type (2021-2032) Figure 46. China Multiplex Molecular Diagnosis Technology Revenue Share by Application (2021-2032) Figure 47. Asia Multiplex Molecular Diagnosis Technology Revenue YoY Growth (2021-2032) & (US$ Million) Figure 48. Asia Multiplex Molecular Diagnosis Technology Revenue Share by Type (2021-2032) Figure 49. Asia Multiplex Molecular Diagnosis Technology Revenue Share by Application (2021-2032) Figure 50. Asia Multiplex Molecular Diagnosis Technology Revenue Share by Region (2021-2032) Figure 51. Japan Multiplex Molecular Diagnosis Technology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. South Korea Multiplex Molecular Diagnosis Technology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. India Multiplex Molecular Diagnosis Technology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Australia Multiplex Molecular Diagnosis Technology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Taiwan Multiplex Molecular Diagnosis Technology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Southeast Asia Multiplex Molecular Diagnosis Technology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. SAMEA Multiplex Molecular Diagnosis Technology Revenue YoY Growth (2021-2032) & (US$ Million) Figure 58. SAMEA Multiplex Molecular Diagnosis Technology Revenue Share by Type (2021-2032) Figure 59. SAMEA Multiplex Molecular Diagnosis Technology Revenue Share by Application (2021-2032) Figure 60. SAMEA Multiplex Molecular Diagnosis Technology Revenue Share by Country (2021-2032) Figure 61. Brazil Multiplex Molecular Diagnosis Technology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Argentina Multiplex Molecular Diagnosis Technology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Chile Multiplex Molecular Diagnosis Technology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Colombia Multiplex Molecular Diagnosis Technology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Peru Multiplex Molecular Diagnosis Technology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Saudi Arabia Multiplex Molecular Diagnosis Technology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Israel Multiplex Molecular Diagnosis Technology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. UAE Multiplex Molecular Diagnosis Technology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Turkey Multiplex Molecular Diagnosis Technology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Iran Multiplex Molecular Diagnosis Technology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Egypt Multiplex Molecular Diagnosis Technology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Real-time PCR
  • Nested PCR with Melt Curve Analysis
  • PCR with Low Density Microarray
  • PCR with Liquid Phase Bead Array
  • PCR with Electrochemical Detection
Applications
  • Hospital
  • Outpatient Surgery Centre
  • Others
Companies covered
  • Siemens
  • Hologic
  • Thermo Fisher Scientific
  • Koninklijke Philips N.V.
  • NeuroLogica
  • Shimadzu Medical
  • GENERAL ELECTRIC
  • Sysmex
  • Canon
  • FUJIFILM Holdings
  • Bio-Rad Laboratories
  • Roche Diagnostics
  • Luminex Corporation
  • Abbott Laboratories
  • QIAGEN

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Multiplex Molecular Diagnosis Technology Market by Type
  3. 1.2.1 Global Multiplex Molecular Diagnosis Technology Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Real-time PCR
  5. 1.2.3 Nested PCR with Melt Curve Analysis
  6. 1.2.4 PCR with Low Density Microarray
  7. 1.2.5 PCR with Liquid Phase Bead Array
  8. 1.2.6 PCR with Electrochemical Detection
  9. 1.3 Multiplex Molecular Diagnosis Technology Market by Application
  10. 1.3.1 Global Multiplex Molecular Diagnosis Technology Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Hospital
  12. 1.3.3 Outpatient Surgery Centre
  13. 1.3.4 Others
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Multiplex Molecular Diagnosis Technology Market Dynamics
  1. 2.1 Multiplex Molecular Diagnosis Technology Industry Trends
  2. 2.2 Multiplex Molecular Diagnosis Technology Industry Drivers
  3. 2.3 Multiplex Molecular Diagnosis Technology Industry Opportunities and Challenges
  4. 2.4 Multiplex Molecular Diagnosis Technology Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Multiplex Molecular Diagnosis Technology Market Perspective (2021-2032)
  2. 3.2 Global Multiplex Molecular Diagnosis Technology Growth Trends by Region
  3. 3.2.1 Global Multiplex Molecular Diagnosis Technology Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Multiplex Molecular Diagnosis Technology Market Size by Region (2021-2026)
  5. 3.2.3 Global Multiplex Molecular Diagnosis Technology Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Multiplex Molecular Diagnosis Technology Revenue by Players
  2. 4.1.1 Global Multiplex Molecular Diagnosis Technology Revenue by Players (2021-2026)
  3. 4.1.2 Global Multiplex Molecular Diagnosis Technology Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Multiplex Molecular Diagnosis Technology Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Multiplex Molecular Diagnosis Technology Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Multiplex Molecular Diagnosis Technology Key Players Headquarters & Area Served
  7. 4.4 Global Multiplex Molecular Diagnosis Technology Players, Product Type & Application
  8. 4.5 Global Multiplex Molecular Diagnosis Technology Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Multiplex Molecular Diagnosis Technology Market CR5 and HHI
  11. 4.6.3 2025 Multiplex Molecular Diagnosis Technology Tier 1, Tier 2, and Tier 3
5 Multiplex Molecular Diagnosis Technology Market Size by Type
  1. 5.1 Global Multiplex Molecular Diagnosis Technology Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Multiplex Molecular Diagnosis Technology Revenue by Type (2021-2032)
  3. 5.3 Global Multiplex Molecular Diagnosis Technology Revenue Market Share by Type (2021-2032)
6 Multiplex Molecular Diagnosis Technology Market Size by Application
  1. 6.1 Global Multiplex Molecular Diagnosis Technology Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Multiplex Molecular Diagnosis Technology Revenue by Application (2021-2032)
  3. 6.3 Global Multiplex Molecular Diagnosis Technology Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Siemens
  2. 7.1.1 Siemens Company Information
  3. 7.1.2 Siemens Business Overview
  4. 7.1.3 Siemens Multiplex Molecular Diagnosis Technology Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Siemens Multiplex Molecular Diagnosis Technology Product Portfolio
  6. 7.1.5 Siemens Recent Developments
  7. 7.2 Hologic
  8. 7.2.1 Hologic Company Information
  9. 7.2.2 Hologic Business Overview
  10. 7.2.3 Hologic Multiplex Molecular Diagnosis Technology Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Hologic Multiplex Molecular Diagnosis Technology Product Portfolio
  12. 7.2.5 Hologic Recent Developments
  13. 7.3 Thermo Fisher Scientific
  14. 7.3.1 Thermo Fisher Scientific Company Information
  15. 7.3.2 Thermo Fisher Scientific Business Overview
  16. 7.3.3 Thermo Fisher Scientific Multiplex Molecular Diagnosis Technology Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Thermo Fisher Scientific Multiplex Molecular Diagnosis Technology Product Portfolio
  18. 7.3.5 Thermo Fisher Scientific Recent Developments
  19. 7.4 Koninklijke Philips N.V.
  20. 7.4.1 Koninklijke Philips N.V. Company Information
  21. 7.4.2 Koninklijke Philips N.V. Business Overview
  22. 7.4.3 Koninklijke Philips N.V. Multiplex Molecular Diagnosis Technology Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Koninklijke Philips N.V. Multiplex Molecular Diagnosis Technology Product Portfolio
  24. 7.4.5 Koninklijke Philips N.V. Recent Developments
  25. 7.5 NeuroLogica
  26. 7.5.1 NeuroLogica Company Information
  27. 7.5.2 NeuroLogica Business Overview
  28. 7.5.3 NeuroLogica Multiplex Molecular Diagnosis Technology Revenue and Gross Margin (2021-2026)
  29. 7.5.4 NeuroLogica Multiplex Molecular Diagnosis Technology Product Portfolio
  30. 7.5.5 NeuroLogica Recent Developments
  31. 7.6 Shimadzu Medical
  32. 7.6.1 Shimadzu Medical Company Information
  33. 7.6.2 Shimadzu Medical Business Overview
  34. 7.6.3 Shimadzu Medical Multiplex Molecular Diagnosis Technology Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Shimadzu Medical Multiplex Molecular Diagnosis Technology Product Portfolio
  36. 7.6.5 Shimadzu Medical Recent Developments
  37. 7.7 GENERAL ELECTRIC
  38. 7.7.1 GENERAL ELECTRIC Company Information
  39. 7.7.2 GENERAL ELECTRIC Business Overview
  40. 7.7.3 GENERAL ELECTRIC Multiplex Molecular Diagnosis Technology Revenue and Gross Margin (2021-2026)
  41. 7.7.4 GENERAL ELECTRIC Multiplex Molecular Diagnosis Technology Product Portfolio
  42. 7.7.5 GENERAL ELECTRIC Recent Developments
  43. 7.8 Sysmex
  44. 7.8.1 Sysmex Company Information
  45. 7.8.2 Sysmex Business Overview
  46. 7.8.3 Sysmex Multiplex Molecular Diagnosis Technology Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Sysmex Multiplex Molecular Diagnosis Technology Product Portfolio
  48. 7.8.5 Sysmex Recent Developments
  49. 7.9 Canon
  50. 7.9.1 Canon Company Information
  51. 7.9.2 Canon Business Overview
  52. 7.9.3 Canon Multiplex Molecular Diagnosis Technology Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Canon Multiplex Molecular Diagnosis Technology Product Portfolio
  54. 7.9.5 Canon Recent Developments
  55. 7.10 FUJIFILM Holdings
  56. 7.10.1 FUJIFILM Holdings Company Information
  57. 7.10.2 FUJIFILM Holdings Business Overview
  58. 7.10.3 FUJIFILM Holdings Multiplex Molecular Diagnosis Technology Revenue and Gross Margin (2021-2026)
  59. 7.10.4 FUJIFILM Holdings Multiplex Molecular Diagnosis Technology Product Portfolio
  60. 7.10.5 FUJIFILM Holdings Recent Developments
  61. 7.11 Bio-Rad Laboratories
  62. 7.11.1 Bio-Rad Laboratories Company Information
  63. 7.11.2 Bio-Rad Laboratories Business Overview
  64. 7.11.3 Bio-Rad Laboratories Multiplex Molecular Diagnosis Technology Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Bio-Rad Laboratories Multiplex Molecular Diagnosis Technology Product Portfolio
  66. 7.11.5 Bio-Rad Laboratories Recent Developments
  67. 7.12 Roche Diagnostics
  68. 7.12.1 Roche Diagnostics Company Information
  69. 7.12.2 Roche Diagnostics Business Overview
  70. 7.12.3 Roche Diagnostics Multiplex Molecular Diagnosis Technology Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Roche Diagnostics Multiplex Molecular Diagnosis Technology Product Portfolio
  72. 7.12.5 Roche Diagnostics Recent Developments
  73. 7.13 Luminex Corporation
  74. 7.13.1 Luminex Corporation Company Information
  75. 7.13.2 Luminex Corporation Business Overview
  76. 7.13.3 Luminex Corporation Multiplex Molecular Diagnosis Technology Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Luminex Corporation Multiplex Molecular Diagnosis Technology Product Portfolio
  78. 7.13.5 Luminex Corporation Recent Developments
  79. 7.14 Abbott Laboratories
  80. 7.14.1 Abbott Laboratories Company Information
  81. 7.14.2 Abbott Laboratories Business Overview
  82. 7.14.3 Abbott Laboratories Multiplex Molecular Diagnosis Technology Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Abbott Laboratories Multiplex Molecular Diagnosis Technology Product Portfolio
  84. 7.14.5 Abbott Laboratories Recent Developments
  85. 7.15 QIAGEN
  86. 7.15.1 QIAGEN Company Information
  87. 7.15.2 QIAGEN Business Overview
  88. 7.15.3 QIAGEN Multiplex Molecular Diagnosis Technology Revenue and Gross Margin (2021-2026)
  89. 7.15.4 QIAGEN Multiplex Molecular Diagnosis Technology Product Portfolio
  90. 7.15.5 QIAGEN Recent Developments
8 North America
  1. 8.1 North America Multiplex Molecular Diagnosis Technology Revenue (2021-2032)
  2. 8.2 North America Multiplex Molecular Diagnosis Technology Revenue by Type (2021-2032)
  3. 8.2.1 North America Multiplex Molecular Diagnosis Technology Revenue by Type (2021-2026)
  4. 8.2.2 North America Multiplex Molecular Diagnosis Technology Revenue by Type (2027-2032)
  5. 8.3 North America Multiplex Molecular Diagnosis Technology Revenue Share by Type (2021-2032)
  6. 8.4 North America Multiplex Molecular Diagnosis Technology Revenue by Application (2021-2032)
  7. 8.4.1 North America Multiplex Molecular Diagnosis Technology Revenue by Application (2021-2026)
  8. 8.4.2 North America Multiplex Molecular Diagnosis Technology Revenue by Application (2027-2032)
  9. 8.5 North America Multiplex Molecular Diagnosis Technology Revenue Share by Application (2021-2032)
  10. 8.6 North America Multiplex Molecular Diagnosis Technology Revenue by Country
  11. 8.6.1 North America Multiplex Molecular Diagnosis Technology Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Multiplex Molecular Diagnosis Technology Revenue by Country (2021-2026)
  13. 8.6.3 North America Multiplex Molecular Diagnosis Technology Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Multiplex Molecular Diagnosis Technology Revenue (2021-2032)
  2. 9.2 Europe Multiplex Molecular Diagnosis Technology Revenue by Type (2021-2032)
  3. 9.2.1 Europe Multiplex Molecular Diagnosis Technology Revenue by Type (2021-2026)
  4. 9.2.2 Europe Multiplex Molecular Diagnosis Technology Revenue by Type (2027-2032)
  5. 9.3 Europe Multiplex Molecular Diagnosis Technology Revenue Share by Type (2021-2032)
  6. 9.4 Europe Multiplex Molecular Diagnosis Technology Revenue by Application (2021-2032)
  7. 9.4.1 Europe Multiplex Molecular Diagnosis Technology Revenue by Application (2021-2026)
  8. 9.4.2 Europe Multiplex Molecular Diagnosis Technology Revenue by Application (2027-2032)
  9. 9.5 Europe Multiplex Molecular Diagnosis Technology Revenue Share by Application (2021-2032)
  10. 9.6 Europe Multiplex Molecular Diagnosis Technology Revenue by Country
  11. 9.6.1 Europe Multiplex Molecular Diagnosis Technology Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Multiplex Molecular Diagnosis Technology Revenue by Country (2021-2026)
  13. 9.6.3 Europe Multiplex Molecular Diagnosis Technology Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Multiplex Molecular Diagnosis Technology Revenue (2021-2032)
  2. 10.2 China Multiplex Molecular Diagnosis Technology Revenue by Type (2021-2032)
  3. 10.2.1 China Multiplex Molecular Diagnosis Technology Revenue by Type (2021-2026)
  4. 10.2.2 China Multiplex Molecular Diagnosis Technology Revenue by Type (2027-2032)
  5. 10.3 China Multiplex Molecular Diagnosis Technology Revenue Share by Type (2021-2032)
  6. 10.4 China Multiplex Molecular Diagnosis Technology Revenue by Application (2021-2032)
  7. 10.4.1 China Multiplex Molecular Diagnosis Technology Revenue by Application (2021-2026)
  8. 10.4.2 China Multiplex Molecular Diagnosis Technology Revenue by Application (2027-2032)
  9. 10.5 China Multiplex Molecular Diagnosis Technology Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Multiplex Molecular Diagnosis Technology Revenue (2021-2032)
  2. 11.2 Asia Multiplex Molecular Diagnosis Technology Revenue by Type (2021-2032)
  3. 11.2.1 Asia Multiplex Molecular Diagnosis Technology Revenue by Type (2021-2026)
  4. 11.2.2 Asia Multiplex Molecular Diagnosis Technology Revenue by Type (2027-2032)
  5. 11.3 Asia Multiplex Molecular Diagnosis Technology Revenue Share by Type (2021-2032)
  6. 11.4 Asia Multiplex Molecular Diagnosis Technology Revenue by Application (2021-2032)
  7. 11.4.1 Asia Multiplex Molecular Diagnosis Technology Revenue by Application (2021-2026)
  8. 11.4.2 Asia Multiplex Molecular Diagnosis Technology Revenue by Application (2027-2032)
  9. 11.5 Asia Multiplex Molecular Diagnosis Technology Revenue Share by Application (2021-2032)
  10. 11.6 Asia Multiplex Molecular Diagnosis Technology Revenue by Country
  11. 11.6.1 Asia Multiplex Molecular Diagnosis Technology Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Multiplex Molecular Diagnosis Technology Revenue by Country (2021-2026)
  13. 11.6.3 Asia Multiplex Molecular Diagnosis Technology Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Multiplex Molecular Diagnosis Technology Revenue (2021-2032)
  2. 12.2 SAMEA Multiplex Molecular Diagnosis Technology Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Multiplex Molecular Diagnosis Technology Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Multiplex Molecular Diagnosis Technology Revenue by Type (2027-2032)
  5. 12.3 SAMEA Multiplex Molecular Diagnosis Technology Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Multiplex Molecular Diagnosis Technology Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Multiplex Molecular Diagnosis Technology Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Multiplex Molecular Diagnosis Technology Revenue by Application (2027-2032)
  9. 12.5 SAMEA Multiplex Molecular Diagnosis Technology Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Multiplex Molecular Diagnosis Technology Revenue by Country
  11. 12.6.1 SAMEA Multiplex Molecular Diagnosis Technology Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Multiplex Molecular Diagnosis Technology Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Multiplex Molecular Diagnosis Technology Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst